Researchers at Princeton have determined how five cellular proteins contribute to an essential step in the life cycle of hepatitis B virus (HBV). The article describing these findings appeared March 11, 2021 in the journal ...
Mar 11, 2021
0
30
The study, conducted by an international team and led by RMIT University's Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing ...
Aug 11, 2020
0
191
Only about 5% of babies born to mothers with hepatitis C are themselves infected by the disease. A possible reason for this low figure is that the baby's immune system has already destroyed the virus before birth. Researchers ...
Apr 27, 2020
0
161
Researchers at Princeton University have identified a set of human proteins that the hepatitis B virus (HBV) uses to establish itself permanently inside liver cells. The study, published in the journal Nature Microbiology, ...
Mar 9, 2020
0
83
Scientists from the German Cancer Research Center systematically investigated the DNA of more than 2,600 tumor samples from patients with 38 types of cancer to discover traces of viruses, which they found in 13 percent of ...
Feb 5, 2020
0
29
By comparing needles and syringes to disease-carrying mosquitoes, an innovative mathematical model of how the Hepatitis C virus spreads is offering scientists new perspectives on how best to prevent its proliferation.
Sep 4, 2019
0
18
Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection, according ...
Apr 30, 2019
0
29
Liver cells have an innate resistance to RNA viral infections like hepatitis A, dengue and Zika thanks to a protein called IRF1, according to researchers at the University of North Carolina at Chapel Hill (UNC) and Tokyo ...
Apr 15, 2019
0
126
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...
Apr 9, 2019
0
22
One of the commonest causes of congenital disability, the Human Cytomegalovirus (HCMV), is less prone to mutation than previously thought, a finding which could help develop a successful vaccine, UCL researchers have found.
Feb 25, 2019
0
34
